CuraSen Therapeutics, Inc.

CuraSen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of small molecule therapies to treat neurodegenerative and neuropsychiatric diseases, including Alzheimer's and Parkinson's. The company develops drug candidates that target novel mechanisms in the brain to restore and preserve brain health, modify disease pathology, and alleviate disabling symptoms by activating innate homeostatic pathways.